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ABSTRACT Cattle are a reservoir for Shiga toxin-producing Escherichia coli (STEC), zoo-
notic pathogens that cause serious clinical disease. Scotland has a higher incidence of
STEC infection in the human population than the European average. The aim of this
study was to investigate the prevalence and epidemiology of non-O157 serogroups
O26, O103, O111, and O145 and Shiga toxin gene carriage in Scottish cattle. Fecal sam-
ples (n=2783) were collected from 110 herds in 2014 and 2015 and screened by real-
time PCR. Herd-level prevalence (95% confidence interval [CI]) for O103, O26, and O145
was estimated as 0.71 (0.62, 0.79), 0.43 (0.34, 0.52), and 0.23 (0.16, 0.32), respectively.
Only two herds were positive for O111. Shiga toxin prevalence was high in both herds
and pats, particularly for stx2 (herd level: 0.99; 95% CI: 0.94, 1.0). O26 bacterial strains
were isolated from 36 herds on culture. Fifteen herds yielded O26 stx-positive isolates
that additionally harbored the intimin gene; six of these herds shed highly pathogenic
stx2-positive strains. Multiple serogroups were detected in herds and pats, with only 25
herds negative for all serogroups. Despite overlap in detection, regional and seasonal
effects were observed. Higher herd prevalence for O26, O103, and stx1 occurred in the
South West, and this region was significant for stx2 at the pat level (P=0.015).
Significant seasonal variation was observed for O145 prevalence, with the highest preva-
lence in autumn (P=0.032). Negative herds were associated with Central Scotland and
winter. Herds positive for all serogroups were associated with autumn and larger herd
size and were not housed at sampling.
IMPORTANCE Cattle are reservoirs for Shiga toxin-producing Escherichia coli (STEC), bac-
teria shed in animal feces. Humans are infected through consumption of contaminated
food or water and by direct contact, resulting in serious disease and kidney failure in
the most vulnerable. The contribution of non-O157 serogroups to STEC illness was
underestimated for many years due to the lack of specific tests. Recently, non-O157
human cases have increased, with O26 STEC of particular note. It is therefore vital to
investigate the level and composition of non-O157 in the cattle reservoir and to com-
pare them historically and by the clinical situation. In this study, we found cattle preva-
lence high for toxin, as well as for O103 and O26 serogroups. Pathogenic O26 STEC
were isolated from 14% of study herds, with toxin subtypes similar to those seen in
Scottish clinical cases. This study highlights the current risk to public health from non-
O157 STEC in Scottish cattle.
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Shiga toxin-producing Escherichia coli (STEC) strains are zoonotic bacteria that causea spectrum of disease in humans, from asymptomatic carriage or mild diarrhea
through to hemorrhagic colitis and hemolytic uremic syndrome (HUS) (1). The bacteria
produce several virulence factors, of which Shiga toxin (Stx) is the predominant causa-
tive factor responsible for severe pathology. Stx is expressed by lysogenic bacterio-
phages incorporated into the bacterial genome (2). There are two known types of Stx,
encoded by the stx1 and stx2 genes; variant subtypes of these genes occur (3), with the
subtypes stx2a, stx2c, and stx2d more commonly associated with serious disease (1, 4). A
subset of STEC strains, designated enterohemorrhagic E. coli (EHEC), additionally carry
the eae gene for the virulence factor intimin, which mediates attachment to the intesti-
nal mucosa and increases infection severity (1, 5).
In 1982, E. coli O157 was the first STEC serogroup identified as the causal pathogen
in human cases of severe hemorrhagic colitis and HUS (6). The majority of O157 STEC
strains differ from commensal and other pathogenic E. coli bacteria in their inability to
ferment sorbitol, a characteristic exploited by selective culture media, enabling O157
STEC to be distinguished from other serogroups (7). Public health surveillance pro-
grams based on such methodologies were developed around the world from the late
1980s in order to aid diagnosis and track the epidemiological spread of O157 (1, 8).
There are many non-O157 serogroups that also carry stx genes and cause severe
human disease (9). Due to the lack of specific diagnostic tests, for many years the con-
tribution of these non-O157 STEC to clinical disease has been substantially underesti-
mated (10). However, recent progress in the development of culture-independent mo-
lecular assays that detect stx and other virulence genes has markedly increased the
number of infections attributed to non-O157 STEC worldwide (11). Non-O157 STEC
strains are now frequently identified as the primary pathogen in both sporadic and
clinical outbreaks of severe disease, including HUS and death (4, 12). Consequently, a
new classification system has recently been proposed, the JEMRA scheme (13), based
upon virulence gene composition. Under this scheme, STEC strains carrying the stx2a
gene (with or without stx1a) together with eae are classified as JEMRA level 1, the most
pathogenic tier, capable of inducing bloody diarrhea and HUS.
While in many countries O157 STEC remains the single most commonly reported
serogroup in clinical cases, the proportion of STEC illness attributed to combined non-
O157 serogroups now exceeds that attributed to O157. The predominance of non-
O157 STEC has become evident over the past decade, particularly in Ireland (14), the
wider European Union/European Economic Area region (15), and the United States
(16–18). This is due in part to the change in methodology of molecular-based assays,
as well as to mandatory requirements to report non-O157 STEC cases in many coun-
tries. O26 is the second most frequently reported STEC serogroup, and in some coun-
tries, including Ireland, France, Italy, and Denmark, clinical O26 cases currently surpass
those due to O157 (19). Non-O157 infections appear to be of particular clinical signifi-
cance in pediatric patients, in whom disease severity is similar to that of O157 (20, 21).
Recent outbreaks of highly pathogenic stx21 eae1 O26:H11 serotype strains have caused
multiple HUS cases in young children, notably in France, Italy, and Romania (22–25). O26:
H11 strains now account for a greater proportion of HUS cases than do O157 STEC strains
in the European Union (12) and are of emerging importance.
Within the United Kingdom, Scotland has a particularly high incidence of STEC
infection, and in 2019 the reported rate for all STEC was 4.7 per 100,000 population,
approximately double the European Union average (12, 26). The proportion of non-
O157 STEC cases has increased over the last decade in Scotland, accounting for approxi-
mately 40% of clinical reports since 2018 (26). In England, there is no standardized screen-
ing for non-O157 STEC; however, between 2013 and 2017, a regional survey reported that
non-O157 serogroups comprised more than 80% of clinical isolates (27). Non-O157 STEC
strains therefore represent an increasing public health concern.
Ruminants are the primary animal reservoir for STEC, predominantly farmed cattle
and sheep (28), although recent reports of STEC isolation from wild animals, including
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deer and birds, suggest widespread dissemination of these pathogens across differing
environmental niches (29–31). Generally, STEC bacteria do not cause significant mor-
bidity or affect productivity in livestock and have therefore not been an economic pri-
ority for farm-level control. Management of transmission to humans is currently reliant
on hygiene interventions by food business operators and public education on the risks
associated with consumption of raw or undercooked meat and unpasteurized dairy
products. Control within rural environments depends on hygiene measures such as
hand-washing, together with an awareness of the risks posed by livestock contact and
untreated water sources.
With the current rise in clinical cases attributed to non-O157 serogroups, livestock
surveillance remains an important tool for measuring public health risk, as recom-
mended in the Scottish Government Action Plan (32). Prevalence estimates provide an
indication of the size of potential animal reservoirs, while epidemiological analyses aid
the identification of geographic and husbandry factors that may be associated with
livestock carriage. Between 2002 and 2004, a cross-sectional survey of beef cattle in
Scotland estimated O26 herd prevalence to be equivalent to that of E. coli O157, at
23% (33). A new national survey was conducted in 2014–2015, the British E. coli O157
in Cattle Study (BECS) (34). BECS highlighted the stable epidemiological level of O157
STEC in Scottish cattle, with carriage observed in about one-fifth of sampled herds.
In this study, we aimed to assess current prevalence levels for O26, O103, O111, and
O145 serogroups, together with stx gene carriage, in the Scottish cattle component of
BECS using a PCR-based method (35). Determining cooccurrence of stx and target O
groups is important for assessing the potential risk of new stx strain emergence, where
receptive serogroup backgrounds and stx gene reservoirs coincide (36). We investi-
gated possible risk factors associated with herd prevalence, such as region, season,
and farm management. Finally, we isolated O26 strains from positive herds in order to
assess the proportion shedding pathogenic stx-positive strains.
RESULTS
Overall pat- and herd-level prevalence, Scotland, 2014–2015. A total of 110
herds and 2,783 pat samples (median of 23 pats per herd, range 1 to 75) were tested
by real-time PCR for the stx1, stx2, O26 wzx, O103 wzx, O111 wbdL, and O145 wzy genes
(Table 1). Shiga toxin gene carriage was high in the study population; over the 110
sampled herds, all but one were positive for stx2 and 91 were positive for stx1. Similarly,
over the 2,783 pat samples, 70.2% and 40.2% were positive for stx2 and stx1, respec-
tively. The most frequently observed serogroup in the study population was O103, fol-
lowed by O26 and then O145. In contrast, O111 was rare, detected in less than 0.2% of
pats, in only two herds.
We examined how within-herd prevalence for O26, O103, O145, and stx genes may
vary between herds (Fig. 1). For O26 and O145, the distribution was highly skewed
right, with more than 80% and 90% of herds, respectively, showing a within-herd prev-
alence of ,20%. The within-herd prevalence for O103 showed a bimodal distribution,
TABLE 1 The number of study herds and pats testing PCR positive for Shiga toxin genes and
the four non-O157 serogroups O26, O103, O111, and O145
Target
Herd (n=110) Pat (n=2,783)
n % n %
stx1 91 82.7 1,118 40.2
stx2 109 99.1 1,955 70.2
O26 47 42.7 420 15.1
O103 78 70.9 1,102 39.6
O111 2 1.8 4 0.2
O145 25 22.7 152 5.5
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with 47% of herds having ,20% positive pats but with 23% of herds showing over
80% positive pats (median 25%, range 0 to 100%). The distribution for stx2 was skewed
left, and 38% of herds had a within-herd prevalence of over 80%. In contrast, stx1
showed a more even distribution in pat prevalence across herds (median 36%, range 0
to 100%).
A generalized linear mixed model (GLMM) was used to estimate herd- and pat-level
prevalence values for Scotland (Fig. 2 and Tables S3 and S7). The mean herd-level prev-
alence estimates (95% CI) obtained were 70.9% (61.6, 78.7) for serogroup O103, 42.7%
(33.7, 52.3) for O26, and 22.7% (15.8, 31.6) for O145. It was not possible to generate an
estimate for the O111 serogroup due to low frequency. stx gene carriage was ubiqui-
tous throughout Scotland, estimated at the herd level as 82.7% (74.4, 88.8) for stx1 and
99.1% (93.7, 99.9) for stx2.
FIG 1 Within-herd prevalence distribution for O26, O103, and O145 serogroups, and stx1 and stx2
gene targets, as proportion of pats (n= 2783) positive per herd (n= 110), in decile categories up to
1.0 (x axis) versus proportion of herds (y axis).
FIG 2 Prevalence estimates for herds (n= 110) and pats (n= 2,783) testing PCR positive for O26,
O103, and O145 serogroups and stx genes, Scotland, 2014–2015. Error bars denote 95% CI.
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Seasonal and geographical distributions. Seasonal effects on gene carriage were
examined across the four seasons of the year. The highest herd prevalence occurred
during the autumn for O26, O103, and O145 and was lowest during the winter months
for O103 and O145 and during spring for O26 (Table S3). For stx1, the highest preva-
lence was in the spring. Season was analyzed within the GLMM across all serogroups;
although the estimates for herd prevalence were highest in the autumn for O26, O145,
and O103, this was only statistically significant for O145 (overall P value of 0.004; pair-
wise autumn to winter P value of 0.032).
The prevalence of positive herds by animal health district (AHD) was examined to
investigate possible spatial variation across Scotland. The herd-level prevalence within
the study population was highest in the South West of Scotland for O26, O103, and
FIG 3 Observed herd prevalence by Animal Health District region for E. coli O26, O103, O145, and stx1 by real-time
PCR, Scotland, 2014–2015.
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stx1 and was lowest in the Central areas for O103 and stx1 and in the Central and
Islands areas for O26 (Fig. 3). There was no apparent regional distribution in O145-posi-
tive herds, although this was lowest in the Central AHD. Regional herd- and pat-level
estimates were calculated within the GLMM (Tables S3 and S7). The highest herd prev-
alence for O26 and O103 was estimated for the South West, and the lowest was esti-
mated in the Central and Islands areas. All regions showed a high prevalence at the
herd level for stx1, highest in the South West and lowest in Central. It was not possible
to examine herd-level spatial distribution for stx2, since most herds tested positive
(109/110); however, there was a statistically significant difference in stx2 pat-level prev-
alence between regions (P = 0.015). The highest stx2 pat prevalence was in the South
West, 81.1% (95% CI: 72.3, 87.6), and the lowest was in the Islands, 56.3% (95% CI: 41.7,
69.9) (pairwise comparison, P = 0.03). The two positive O111 herds were located in the
South West and South East, while the single stx2-negative herd was present in the
Islands.
Multiple serogroups and stxwithin herds and pats. The majority of herds showed
a positive result for at least one of the target serogroups, with only 21.8% of herds
(n=25) negative for all serogroups tested, 34.5% (n=39) positive for a single serogroup,
and 41.8% (n=46) positive for two or more serogroups. The combination of O26 and
O103 was the most commonly detected pattern at the herd level. Tetrachoric correlation
analysis showed the strongest correlation between O103 and O145 serogroups (rtet =
0.99), with all O145-positive herds also testing O103 positive. A moderate association was
also observed between O26 and O145 (rtet = 0.64) and for O26 and O103 (rtet = 0.57)
serogroups. Both O111-positive herds were also O26 and O103 positive, with one addition-
ally O145 positive. Regionally, Central and the Islands had the greatest number of herds
negative for the four non-O157 serogroups (37.5%) investigated, while there were no
herds in the South West negative to all.
To examine within-sample combinations for a positive PCR status between the four
serogroups and stx, a single index event per herd for each combination of the six
genes tested was recorded. Further occurrences of a combination were excluded to
prevent herds with large numbers of pats from dominating the analysis. A total of 31
possible PCR gene target combinations were observed across 491 combination events,
with a median per herd of four different combinations (range, 1 to 12) (Fig. 4a). For all
FIG 4 Positive pat PCR target combinations observed across all herds (n= 110) for n= 491 sample events depicting (a)
Venn diagram showing the frequency of all possible combinations for O26, O103, O145, stx1, and stx2 and (b) tetrachoric
correlation results between paired targets.
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positive pats, 33.8% were positive to both 1 and 2 targets, 21.8% were positive to 3, 8.2%
to 4, 2.2% to 5, and only 0.2% to all 6 targets. The most common pattern seen was stx2
(16.7% of events), followed by stx1 stx2 (12.8%) and O103 stx2 (10.6%). Tetrachoric correla-
tion analysis showed a low positive correlation among all the serogroups and stx (Fig. 4b).
The highest association was observed between O103 and either O145 (rtet = 0.39) or O26
(rtet = 0.38). For stx2, the highest correlation was for O145 (rtet = 0.25) and O26 (rtet = 0.23).
Due to low prevalence, correlation was not performed for O111. Thirty-two herds (29.1%)
gave a positive result to at least one gene target for every pat sample tested, and 58.2%
(n=64) of herds had samples positive to three or more targets (Fig. 5). There were no
herds for which every single pat tested was negative to all six of the PCR targets.
Comparison with historical farm data. There were 80 herds in the current study
that had also been previously screened for non-O157 serogroups in the 2002 to 2004
cross-sectional survey (33). No significant association was observed between previous
historical and current herd status (Table 2) for O26 (Pearson’s x 2 = 0.42, P = 0.52), O103
(Pearson’s x 2 = 0.007, P = 0.93), or O145 (Fisher’s exact test, P = 1.0).
Herd risk analysis. Nonmetric multidimensional scaling (NMS) was used to identify
epidemiological survey variables associated with the presence of the non-O157
serogroups (O26, O145, and O103) and STEC O157. The final NMS solution was two-
dimensional (2D) and explained 80.0% (cumulative r2 = 0.800, axis 1 r2 = 0.587 and axis 2
r2 = 0.216) of the variation in the presence of E. coli serogroups in herds. More variation
than expected occurred by chance (Monte Carlo test P=0.004). Final stress for the two-
dimensional solution was 4.09 (final stress ,5 suggests an excellent representation) (37)
and final instability was 0, with 51 iterations. Number of iterations is the number of steps
that NMS performed to find the final solution (38).
The results are shown using 2D ordination graphs of the distance between sample
units, which approximate dissimilarity in the serogroup presence in herds (Fig. 6). The
x axis explains most of the variation in the data (58.7%) and represents herds with no
serogroup identified (left) and herds where all serogroups were identified (right).
Confidence ellipses (75%) highlight herds with each serogroup (Fig. 6a). There is con-
FIG 5 The proportion of herds (n= 110) with at least one sample event in herd for the number of
targets shown (“Any in herd”), and the maximum number of targets per sample observed in a herd
(“Max number in herd”).
TABLE 2 Comparison of current and historical herd serogroup status for all herds (n=80)
tested in both the 2002 to 2004 and 2014–2015 surveys
Serogroup
Herd comparison at both time points
Positive both Negative both Changed status
O26 10 35 35
O103 12 20 48
O145 1 18 61
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FIG 6 Nonmetric multidimensional scaling (NMS) ordination of herd-level serogroup results. (a)
Scatterplot and 75% confidence ellipses round the herds in space illustrating the extent of overlap
between herds with O103, O26, O145, and STEC O157. (b) All epidemiological variables associated
with NMS axes 1 and 2 are shown as vectors radiating from the centroid; the direction indicates
positive or negative association on that axis. AHD denotes Animal Health District.
Hoyle et al. Applied and Environmental Microbiology
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siderable overlap in ellipses, indicating that many herds were positive for more than
one serogroup; however, there was a trend for herds with O26 serogroups in the lower
quadrant and herds with O103 and O145 in the upper quadrant. STEC O157 was associ-
ated with herds in all quadrants. Factors associated with each axis are shown as vectors
(Fig. 6b); the direction indicates positive or negative correlation (not strength) along
the axis. Negative herds were associated with the Central AHD, winter, and herds with
livestock not owned by the farm. Herds with all serogroups identified were associated
with greater numbers of cattle in the herd, autumn, not being housed at the time of
sampling, slurry spreading, and movement of breeding females into the herd. Herds
with both O103 and O145 were associated with potential biosecurity-related variables,
such as bringing cattle into the herd, change in location or of feed, and cattle grazing
with birds. Herds with O26 were associated with larger numbers of cattle in the herd
aged 12 to 30months, the South West (AHD), and reports of cattle health issues within
the last 2weeks.
Isolation and identification of O26 strains from PCR-positive herds.We attempted
isolation of O26 strains from all herds that were O26 PCR positive, using an immuno-
magnetic separation (IMS) technique. IMS was performed on a maximum of eight pat
samples per herd, selecting those with the lowest recorded PCR threshold cycle (Ct) in
order to maximize yield. Strain isolation was not attempted from every PCR-positive
pat in a given herd, since this was beyond the scope of the current study.
O26 strains were isolated from 36 of 47 herds that were O26 PCR positive. The IMS
confirmation rate for PCR-positive herd status was therefore 77%, and a total of 196
O26 isolates were obtained from 64 pat samples. For herds yielding a positive O26 iso-
late, the mean number of PCR-positive pats in the herd was 10, compared to 4 positive
pats per herd for those that did not yield an O26 isolate. Furthermore, herds yielding
an O26 isolate had a significantly lower minimum sample Ct value than that of herds
that failed to generate an O26 isolate (median Ct value of 29.5 versus 33.2, Mann-
Whitney U test, P = 0.004).
Of the 36 herds that generated O26 isolates, 21 herds yielded O26 stx-negative iso-
lates only and 15 herds yielded O26 stx-positive isolates (n=67). Real-time PCR and
Illumina sequencing confirmed that of the O26 stx-positive herds, nine generated O26
stx1a-only isolates, three gave dual-positive stx2a-stx1a isolates, one gave dual-positive
stx2d-stx1a isolates, and two yielded O26 stx2a-only isolates. All the O26 stx-positive iso-
lates were additionally positive for the intimin gene, eae. By region, the proportion of
all herds yielding O26 strains that gave an stx-positive isolate was greater in the
Highlands (0.57) and South West (0.5) than in all other regions (0.3), although this dif-
ference was not statistically significant.
Systematic IMS for isolation of O103 and O145 strains from positive farms was
beyond the scope of this study, due to operational constraints. However, O103 strains
(22 isolates) were isolated from samples in seven herds that were undergoing O26 IMS.
All O103 isolates were stx negative, and in three herds, both O103 and O26 were iso-
lated jointly from the same pats. In addition to the targeted O26 strains, stx-positive
strains of other O serogroups were isolated incidentally from samples in six O26-shed-
ding herds. These strains were identified as stx1a-positive O84, O98, O149, O177, and
O182, as well as O136 (stx2a) and O150 (stx2a-stx1a). Coisolation of strains with O26 from
the same individual pat sample occurred in five of these herds, including individual
pats from two herds for which three serogroups were obtained: O26 plus O103, with
either O155, O177, or O182.
DISCUSSION
Prevalence of stx and O serogroups. In Scotland, the frequency of observed Shiga
toxin gene carriage in cattle was high, with 99% and 83% of herds and 70% and 40%
of pats being stx2 and stx1 positive, respectively. Shiga toxin gene carriage was there-
fore ubiquitous in this study population. To our knowledge, the prevalence of stx has
not been previously estimated for Scottish cattle; the data highlight the widespread
distribution of stx gene carriage in this reservoir. Since we used a culture-independent
Prevalence and Epidemiology of Non-O157 E. coli Applied and Environmental Microbiology
May 2021 Volume 87 Issue 10 e03142-20 aem.asm.org 9
 on A








method, the observed prevalence encompasses stx harbored both by STEC organisms,
i.e., with stx virulence genes incorporated into the bacterial genome, and in free Stx-
encoding bacteriophage. Such high carriage by cattle has been reported in several
countries, including the United States, Canada, Europe, and Australia (39–44). Across all
these studies, the prevalence of stx2 is greater than that of stx1, similar to our own
observations. Comparing exact prevalence values between studies is not always perti-
nent, due to differences in screening methodology and sample population demo-
graphics; however, despite this, the concurrence in high stx prevalence observed in
this survey is notable.
The most common serogroup detected at both herd and pat levels was O103, fol-
lowed by O26 and then O145, with O111 detected in only two herds. This order of fre-
quency differs from that of the 2002 to 2004 survey (33), in which O26 and O103 were
of similar estimated herd prevalence (22 to 23%). Both surveys agreed on the ranking
of O145 and O111, with O111 not previously detected. We estimated a higher PCR-
based prevalence for all three serogroups at both herd and pat level, probably due to
the increased sensitivity of real-time PCR compared to that of the previous culture-
based methodology. Molecular techniques are now routinely employed for STEC diag-
nostics in both clinical and food safety environments (1) and are particularly useful for
identifying non-O157 STEC infection, since these serogroups are difficult to distinguish
on culture from commensal E. coli. We did confirm O26 herd status by strain isolation,
using a similar IMS methodology to that of the 2002 to 2004 survey but with a change
in culture medium to CHROMagar STEC, an agar that supports growth of a wider range
of STEC serogroups (45). O26 shedding was confirmed in 77% of the PCR-positive
herds, i.e., 33% of the overall study population. This is an increase compared to the
proportion of herds yielding O26 strains previously and may be due to a genuine
increase in O26 herd carriage within Scotland or the result of differences in methodol-
ogy, such as the change in selective agar.
The high prevalence of O103 positivity was unexpected but is corroborated by
other studies, with O103 found to be a predominant non-O157 serogroup in dairy cat-
tle in New Zealand (46) and Ireland (47) and in beef cattle in the United States (48, 49),
Canada (50), and Australia (44). Despite high serogroup prevalence, recovered O103
isolates from cattle appear to carry stx genes relatively infrequently (44, 46, 47, 49, 51),
as also observed in the previous Scottish survey (33). O103 would therefore appear to
be of lower public health concern.
We report an overall serogroup prevalence and not STEC-specific O group preva-
lence. Stx-encoding bacteriophage are mobile and may exist freely, while lysogeny
enables incorporation into receptive E. coli backgrounds, allowing Shiga toxin expres-
sion with subsequent pathogenic effect (35, 52). Where reservoirs of Stx-encoding bac-
teriophage coincide with receptive serogroup backgrounds, there exists the potential
for evolution of emergent STEC strains. In particular, O26 stx status is known to be
dynamic, with loss and acquisition of stx phage demonstrated in vitro and in vivo (53–56).
Individual pat samples from two herds in our study yielded both stx-negative and -positive
O26 isolates, suggesting that the source animal was colonized either by two differing O26
strains or by the same strain from which stx genes had been lost or acquired within the
gut or during laboratory culture. Without screening all available pats and a greater number
of colony picks per sample, we cannot definitively state that any given herd was O26 stx
negative.
Multiple serogroup detection. There was a positive correlation observed between
the detection of multiple serogroups at both herd and pat levels. All herds that were
O145 positive formed a subset of O103-positive herds, and the majority of O26-positive
herds were also O103 positive. Coshedding of O26 and O103 within management
groups had been previously observed in the 2002 to 2004 study (33). The increased
sensitivity of PCR here enabled demonstration of cocarriage within individual samples,
confirmed in a small subset by isolation of both O26 and O103 from individual pats.
Other STEC serogroups were also isolated incidentally during IMS, with two herds each
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yielding three different serogroups from individual pats. Cocarriage of non-O157
serogroups in individual cattle is reported elsewhere (57, 58), while a significant posi-
tive association between O103 with O26 or O145 carriage has been observed in indi-
vidual calves (51). Serogroup association is likely a reflection of common environmental
and husbandry factors independently favoring carriage of multiple E. coli serogroups,
although the possibility of serogroup facilitation within niches cannot be discounted.
Comparison with human data in Scotland. Data from an equivalent reporting pe-
riod, 2014–2015, show that O26 was the commonest non-O157 STEC isolated from clin-
ical submissions to the Scottish E. coli O157/STEC Reference Laboratory (SERL), com-
prising 25.4% of total cases, followed by O145 (10.7%) and O103 (6.0%) (personal
communication, Lesley Allison). In the current cattle survey, while the proportion of
herds that were O103 PCR positive was much higher than that of herds that were O26
positive, based on evidence from the 2002 to 2004 survey (33), the majority of these
O103 herds were anticipated to be stx negative. These would be of limited risk to pub-
lic health and therefore presumably less frequently identified in clinical samples. In
contrast, O26 stx-positive strains were isolated from 11.2% of all sampled herds in 2002
to 2004 and from 13.6% of the herds in our current survey. Although the survey was
not designed to be fully representative of the entire Scottish cattle population (59), we
suggest that the cattle reservoir shedding O26 STEC in Scotland is substantial. This is
reflected by the predominance of the O26 serogroup in non-O157 STEC clinical sub-
missions to the SERL.
Further evidence that cattle are implicated as a reservoir for human O26 STEC infec-
tion is given by the stx subtype carried by isolates. Prior to 2010, all clinical O26 strains
submitted to SERL harbored either stx1a or the combination stx2a-stx1a gene profiles;
however, in 2010 the first clinical O26 stx2a-only strains were isolated (60). Since then,
while the majority of clinical O26 strains continue to be either stx1a- or stx1a-stx2a-posi-
tive, a minority of O26 stx2a-only positive cases also occur. These data agree with the
stx strain distribution observed within the two Scottish cattle surveys, in which all O26
STEC strains isolated between 2002 and 2004 were either stx1a- or dual stx1a-stx2a-posi-
tive, with no herds shedding stx2a-only strains. In contrast, despite the smaller survey
sample size, in this study we identified two cattle herds shedding stx2a-only positive
O26 strains. Overall, the distribution of stx subtypes in the O26 STEC shedding herds
was very similar to that observed in clinical strains across the same time period (60).
Isolates from 5 out of the 15 O26 STEC shedding herds met the criteria for JEMRA level
1 (13), while the remainder of the stx-positive herds yielded strains equivalent to
JEMRA level 4. All the identified O26 STEC herds therefore shed bacteria of substantial
public health risk.
Seasonal, spatial, and risk factor analysis. In general, prevalence was higher in
the autumn for both O26 and O103; this was highly significant for O145. Ordination
analysis indicated that herds positive for all serogroups were more associated with
autumn, in cattle not housed at time of sampling, while those negative for all
serogroups were associated with winter. Similar seasonal prevalence of non-O157 is
observed elsewhere, including North America (49, 50, 61) and Ireland (62), with signifi-
cantly lower prevalence observed in cattle in colder winter conditions and the highest
prevalence observed during summer and early autumn. The clinical picture also
reflects these data, with higher summer-to-autumn incidence in human non-O157 case
reports locally in Scotland (26), in wider Europe (12, 63), and in the United States (18),
suggesting that human acquisition is directly influenced by seasonal abundance in the
animal reservoir. Seasonal variability could also be influenced by climate factors, such
as rainfall and ground temperature, together with management practices, including
whether animals are housed or grazed.
The highest herd-level prevalence for O26, O103, and stx1 was observed in the
South West of Scotland, with prevalence lowest in the Central and Island regions;
within the ordination analysis, this effect was greatest for the O26 serogroup. stx2 pat-
level prevalence showed a statistically significant regional effect, with higher positivity
in the South West than in the Islands. The density and distribution of cattle farms by
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management type are not uniform throughout Scotland, due to geographical and cli-
matic factors. Dairy herds are concentrated particularly in the South West, with this
region accounting for 78% of such farms (64). This is reflected in the BECS study demo-
graphic, with 10/14 of the dairy herds sampled in this survey based within the South
West AHD, comprising 43% of the herds tested in the region (34). In contrast, no dairy
farms were sampled in the Islands, Highlands, or North East AHDs. Knowledge of re-
gional health risks is important for local disease control and could aid the targeted
introduction of public health measures, such as increased herd biosecurity, public
health education, and potential vaccination (65).
The role of dairy cattle in zoonotic transmission of STEC has gained recent prominence,
with several O26 STEC outbreaks in Europe linked to consumption of unpasteurized dairy
products (23–25). In New Zealand, a recent survey found that herds positive for O26,
O103, and O145 mapped to regions with a greater proportion of dairy farms (58). While
STEC strains are not generally recognized as primary cattle pathogens, stx-positive
serogroups, particularly O26, are frequently isolated from both healthy and diarrheic calves
(28, 66) and may therefore be more common in environments with high calf production
and stocking densities, which are typical in the dairy sector. Local area cattle density also
appears to be of importance, with studies in both Germany (67) and Ireland (68, 69) dem-
onstrating a significant association between human clinical non-O157 STEC case reports
and regions with high local cattle densities.
Both climate and topography influence farm management type in Scotland, with land
of poor productivity and grazing quality typically in colder upland regions more suited to
extensive beef and sheep farming. Regionally, the South West tends to have a milder cli-
mate than that of other areas of Scotland and has relatively high annual rainfall (70).
Climate, geography, and farm management type are therefore intrinsically linked, which
confounds our ability to distinguish which factors may influence pathogen prevalence.
Additional farm variables associated with serogroup positivity included biosecurity-
type factors such as movement of stock and feed for both O103 and O145. For O26,
the number of cattle aged 12 to 30months and herds reporting health issues were rel-
evant variables. Cattle not housed at the time of sampling, slurry spreading, overall herd
size, and the introduction of breeding females onto farms were associated with herds test-
ing positive for all serogroups examined. Farm movements increase opportunities for both
introduction and dispersal of bacteria, while high local density on a farm provides favor-
able conditions for animal-to-animal transmission (58). For the Scottish data set within the
BECS survey, the introduction of breeding females into a herd and the number of cattle
aged 12 to 30 months were also identified as risk factors that increased the odds of a herd
testing O157 positive (59). The agreement between both the O157 and the non-O157
studies is notable and further substantiates the relevance of such factors in herd
colonization.
Limitations. Discrepancy between the detection of gene signal within samples and
isolation of viable strains is well established within the STEC field (71, 72). Strain isola-
tion confirmed 76.7% of the O26 PCR-positive farms, with those herds not confirmed
having a significantly higher minimum Ct value than that of herds yielding strains. This
isolation rate compares favorably with that reported for clinical isolation (26) and other
livestock studies (46, 47, 51, 71). A number of practical reasons may account for failed
isolation, including the low number of colony picks screened per pat, repeated freeze-
thaw before reculture compromising viability, low bacterial concentration, and IMS
bead efficacy (73, 74).
The farm samples used in this study were collected for the BECS study (34), the pri-
mary aim of which was to provide an estimate of E. coli O157 prevalence in Scottish
beef cattle, comparable to historical surveys (75, 76). The sampling protocol was there-
fore powered to look at overall country prevalence of E. coli O157, and the detection of
seasonal and spatial differences was not taken into account. This is reflected in the lack
of statistical significance despite some clear spatial and temporal effects being
observed in this study. A similar result was found for E. coli O157 (59).
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Conclusion. This study has demonstrated widespread stx gene prevalence in cattle
throughout Scotland. O103 was the most common serogroup, followed by O26, and only
25 farms were negative for all four non-O157 serogroups. Despite limited statistical power,
geographical and seasonal effects were observed, with autumn being the most likely sea-
son to detect all serogroups. Compared to historical data, the prevalence for all non-O157
serogroups examined was higher, mirroring the current pattern observed in Scottish
human clinical cases. All O26 STEC strains isolated were eae positive, with highly patho-
genic stx2-positive strains identified in six herds. These data highlight the importance of
cattle as a non-O157 STEC reservoir of risk to public health in Scotland.
MATERIALS ANDMETHODS
Sample source, study population, and herd epidemiological data. Samples from Scottish cattle
were provided for this study by the British E. coli O157 Cattle Study (BECS) (34) as 2-ml preprepared 6-h
fecal pat enrichment cultures in buffered peptone water (BPW), stored at a final concentration of 15%
(vol/vol) glycerol and frozen at 280°C. Individual bovine fecal pat samples (n= 2783) were collected
over a 13-month period between September 2014 and September 2015 from 110 cattle herds through-
out Scotland. Herds were randomly selected from a population of farms included in two previous sur-
veys carried out between 2002 and 2004 (76) and from 1998 to 2000 (75). Sample size was estimated
using the previous reported prevalence of E. coli O157, which was of an order similar to that of both O26
and O103 prevalence in the 2002 to 2004 survey (33), to ensure similar confidence in the current preva-
lence estimates. The number of samples (fresh fecal pats) collected from each herd was determined by
the number of cattle in the sampling group using a prescribed sampling schedule (76). Individual herd
data were obtained by questionnaire administered at the time of sample collection. Variables collected
included herd size, management, health status, and stock movements. A detailed description of the data
collected is outlined by Henry et al. (34), and a copy of the questionnaire is available upon request from
the corresponding author.
Bacterial control strains. The following bacterial strains, used as positive controls for validation of
real-time PCRs, were gifted by the Scottish E. coli O157/Reference Laboratory (SERL; Lesley Allison):
Paton’s positive (PP1; for stx1, stx2 genes) from the Scottish National Culture Collection, H45 (for the stx2f
gene) from a 2011 European Centre for Disease Control (ECDC) External Quality Assurance (EQA) ring-
trial, and O26, O103, and O145 serogroup strains from a 2005 ECDC EQA ringtrial. E. coli DEC/18B (from
Tom Besser, Washington State University, United States) was used as the O111 serogroup control strain,
and E. coli strain K-12 MG1655 (77) was used as a negative control.
DNA extraction. Frozen fecal enrichments were thawed on ice, and whole DNA was extracted using
InstaGene matrix (Bio-Rad Laboratories Ltd., Watford, UK) spiked with phocine herpesvirus (PhHv) glycopro-
tein B (gifted by Lesley Allison, SERL) as an internal control to verify successful extraction and rule out the
presence of PCR inhibitors (78). Fiftymicroliters of fecal enrichment culture was washed in 950ml of nucle-
ase-free water (Qiagen, Crawley, UK) and cells were pelleted by centrifugation at 13,000 rpm for 3 min.
InstaGene, 200ml, was added to the cell pellet, vortexed, and incubated in a heat block for 60min at 56°C.
Samples were vortexed again and boiled at 100°C for 20min to ensure pathogen killing. The resultant DNA
extract was cooled, the matrix was pelleted by centrifugation at 13,000 rpm for 1min, and the DNA extract
was stored frozen at 280°C until required. A repeat extraction procedure was routinely performed on every
20th fecal enrichment as a biological repeat (BR). For each daily batch of test samples processed, a DNA
extraction was performed on overnight cultures in Luria-Bertani broth (LB broth; Oxoid Ltd., Basingstoke, UK)
of PP1, H45, and MG1655 E. coli strains as positive and negative controls.
Serial dilution of positive-control strains spiked into a negative fecal enrichment background
for determining PCR cutoff. Negative background fecal samples were obtained from young calves (79)
that were prescreened PCR negative for all the relevant gene targets. The fecal samples were preen-
riched similarly to the test fecal pat samples, as described above, and stored frozen in aliquots as 15%
(vol/vol) glycerol cultures at280°C.
Ten-fold serial dilutions of positive strain cultures were prepared in LB broth and spiked into the
negative fecal enrichment culture to provide a biologically relevant control for each PCR target, subject
to any similar inhibitors that may have been present in the test sample fecal enrichments. The spiked
fecal enrichment dilution series was used to determine equivalent designated cutoffs for allocating a
sample to either positive or negative PCR status across the four O serogroups under investigation. We
spiked feces at the postenrichment stage. Spiking at the preenrichment stage may have resulted in
uneven dilution curves and nonequivalent serogroup cutoffs, due to possible differential growth of the
four serogroup control strains within the complex bacterial base of the fecal enrichment culture. The
limit of detection for each PCR target therefore relates to CFU at the 6-h postenrichment stage.
To spike the negative fecal enrichments, a single colony of each positive-control strain was grown
individually overnight in 5ml of LB broth at 37°C in a static incubator. The overnight culture was subcul-
tured 1:100 in LB broth and grown with shaking (200 rpm) at 37°C for 4 h. For each control strain, a 10-
fold serial dilution of the 4 h subculture was prepared in LB broth and individual dilution points were
then spiked into aliquots of the negative fecal enrichment culture. Single strain spiked dilution series
(1021 to 1026) were prepared for all individual control strains by spiking the respective 4-h subculture
dilution point 1:10 into the negative fecal enrichment. Additionally, a triplex spiked dilution series (1022
to 1026) was prepared with O26, O103, and O111 control strains, spiking at a 1:100 ratio into the
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negative fecal enrichment. The control strain bacterial concentration (in CFU/ml) present in the 4-h sub-
culture was determined by droplet count (80), spotting 10-ml droplets of each dilution point of the series
onto sorbitol MacConkey agar plates (Oxoid), incubating overnight at 37°C, and performing colony
counts the following day.
DNA extractions were prepared from each spiked fecal dilution control series using InstaGene matrix,
as described above. Replicate extractions were performed for each dilution point and pooled, and batch
aliquots were prepared for use as technical replicates in respective PCR assays. Aliquots were stored fro-
zen at 220°C until required.
Real-time PCR screening for Shiga toxin genes and O serogroups. Each sample DNA extract was
tested in three separate real-time PCR assays, following ISO guidelines (ISO/TS 13136:2012) (35), with
some modifications developed by the SERL (81); primer and probe sequences are as described in Table
3. The reactions were as follows: (i) Shiga toxin multiplex for stx1, stx2, stx2f variant, and PhHv, (ii) O145
singleplex, and (iii) O serogroup triplex for O26, O103, and O111.
Real-time PCR was performed in a reaction volume of 20ml, in 96-well plates (Bio-Rad), comprising 10ml
QuantiTect Multiplex PCR NoROX master mix (Qiagen), 1ml of 20 primer/probe mix, 7ml of DNase-free
water (Qiagen), and 2ml of sample or control DNA template. The final primer concentration was 0.4mM for
all primers, except for stx2f and PhHv (0.2mM); final hydrolysis probe concentrations were 0.1mM for stx1, stx2,
stx2f, and PhHv and 0.2mM for O26, O103, O111, and O145 probes. The primer annealing temperature was
60°C for the Shiga toxin multiplex and O145 singleplex reactions and 55°C for the triplex serogroup reaction
(O26, O103, and O111). PCR was performed using a CFX 96 machine (Bio-Rad), with the following cycling
conditions: initial denaturation cycle of 95°C for 15min, followed by 40 cycles of 95°C for 15 s and the appro-
priate annealing temperature for 60 s. Primers and dually labeled hydrolysis probes were supplied by
Eurofins Genomics (Wolverhampton, UK) and Eurogentec (Seraing, Belgium).
All test and control samples were loaded as duplicate wells. Each reaction plate included water as a
no-template control, DNA for the appropriate positive-control dilution series, and negative-control strain
MG1655 DNA. The triple (O26, O103, and O111)-spiked control series was used for the O serogroup tri-
plex reaction after demonstrating that serogroup-specific Ct values of triple-spiked cultures did not differ
significantly from those of individual serogroup cultures at the equivalent dilution. Additional controls
included the daily batch DNA extracts from control cultures of PP1, H45, and MG1655 for the Shiga
toxin reaction and the 1021 dilution point for each single culture O26, O103, and O111 series in the tri-
plex O serogroup reaction.
PCR data analysis. CFX Manager software version 3.1 (Bio-Rad) was used to capture data. Identical
fluorophore thresholds (relative fluorescence units) were set and applied to all plates for a given PCR,
TABLE 3 Primer and probe sequences for Shiga toxin, triplex O serogroup, and O145 real-time PCRs
Target Primer and probe sequence, 59 to 39 Fragment size (bp) Reference
Shiga toxin multiplex
stx1 Forward TTTGTYACTGTSACAGCWGAAGCYTTACG 131 35
Reverse CCCCAGTTCARWGTRAGRTCMACRTC
Probe 59:-Yakima Yellow-CTGGATGATCTCAGTGGGCGTTCTTATGTAA-BHQ1
stx2 Forward TTTGTYACTGTSACAGCWGAAGCYTTACG 128 35
Reverse CCCCAGTTCARWGTRAGRTCMACRTC
Probe 59-FAM-TCGTCAGGCACTGTCTGAAACTGCTCC-BHQ1
stx2f Forward TTGTCACAGTGATAGCAGAAGCTCTG 124 81
Reverse CAGTTCAGGGTAAGGTCAACATCC
Probe 59-FAM-CGCTGTCTGAGGCATCTCCGCTTTATAC-BHQ1





O26 wzx Forward CGCGACGGCAGAGAAAATT 135 35
Reverse AGCAGGCTTTTATATTCTCCAACTTT
Probe 59-FAM-CCCCGTTAAATCAATACTATTTCACGAGGTTGA-BHQ1
O103 wzx Forward CAAGGTGATTACGAAAATGCATGT 99 35
Reverse GAAAAAAGCACCCCCGTACTTAT
Probe 59-CY5-CATAGCCTGTTGTTTTAT-BBQ




O145 wzy Forward ATATTGGGCTGCCACTGATGGGAT 310 83
Reverse TATGGCGTACAATGCACCGCAAAC
Probe 59-Texas Red-AGCAGTGGTTCGCGCACAGCATGGT-BHQ2
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stx1 (275), stx2 (275), stx2f (275), PhHv (200), O26 (370), O103 (320), O111 (320), and O145 (375). Raw Ct
values at these thresholds were exported in csv format for further data management and analysis within
the R statistical system (R Core Team 2020) (82).
In order to standardize classification of samples to either a positive or negative status across all
serogroups, we designated the Ct cutoff value for each target serogroup or stx as that equivalent to the
Ct observed in the respective positive-control dilution series at a bacterial concentration equivalent to
1 104 CFU/ml postenrichment. This was the equivalent minimum concentration reliably observed
within the spiked dilution series extracts across all the different serogroup and stx (PP1) control strains.
This cutoff value was calculated on an individual, plate-specific basis, using linear regression of the serial
dilution Ct values and starting CFU/ml to impute the cutoff at 1 104 CFU/ml. This cutoff Ct value was
applied to each test sample mean duplicate well result to allocate the sample status on a plate-specific
basis as either positive or negative.
In addition, the mean 1 104 CFU/ml Ct cutoff value across all plates for a given target was calcu-
lated from the individual plate-specific cutoffs to obtain a mean global value. Global Ct cutoffs were cal-
culated for O26 (35.28), O103 (37.08), O111 (36.43), O145 (36.98), stx1 (35.41), and stx2 (34.63). The global
cutoff was applied to all sample results to allocate status additionally at the global level. Both the plate-
specific and global sample status results were used in subsequent prevalence estimate calculations. All
samples that were designated as having a negative status across all test PCR targets had a confirmed
positive signal for the internal control target PhHv.
A proportion of samples underwent repeat PCR either of the existing DNA extract (technical repli-
cate), particularly where sample status determined overall herd status, or for the routine 20th sample
repeat DNA extract (biological replicate) (Tables S1 and S2). Where replicate status did not agree, a sam-
ple was designated “Border” and the prevalence estimate statistical calculations were repeated, with
sample status results read at both plate-specific and global cutoffs and Border results allocated to first
negative status and then positive status (Fig. S1 and Tables S3 to S10). For all analyses reported in the
results section for the study, the more conservative measure of global cutoff, with Border samples allo-
cated to negative status, was used.
Isolation and identification of O26 strains. Strain isolation was attempted from a subset of sam-
ples in all herds testing O26 PCR positive, selecting those with the lowest recorded O26 Ct values. A max-
imum of eight samples were attempted per herd, where available. We did not attempt strain isolation
from every positive sample in a herd, due to practical and financial constraints. Fecal enrichments were
thawed on ice, diluted 1:5 with BPW (Thermo Fisher Scientific, Loughborough, UK), and incubated over-
night with shaking at 37°C and 190 rpm. Two methods were used to attempt O26 strain isolation: (i)
direct culture, by plating 20ml of overnight culture onto CHROMagar STEC agar (CHROMagar, Paris,
France), and (ii) immunomagnetic separation (IMS) using the semiautomated KingFisher mL machine
(Thermo Fisher Scientific). For IMS, 1ml of overnight culture was mixed with 20ml of Dynabeads EPEC/
VTEC O26 (Applied Biosystems, Thermo Fisher Scientific) and allowed to bind for 25min, washed three
times in phosphate-buffered saline (PBS)-Tween 20 (Sigma-Aldrich, Gillingham, UK) for 3min each, and
then eluted in PBS-Tween 20. Eluted beads were plated in 20ml volumes onto each of CHROMagar STEC
agar and UTI ChromoSelect agar (Sigma-Aldrich). Inoculated plates were incubated overnight at 37°C.
Up to 7 individual colonies were picked from all available plates, selecting mauve colonies on CHROMagar
STEC agar and pink-red colonies from UTI ChromoSelect. Picks were subcultured overnight on LB agar at
37°C, and resulting pure cultures of putative strains were stored on cryogenic Microbank beads (Pro-Lab
Diagnostics Inc., ON, Canada), frozen at280°C.
Latex agglutination and real-time PCR were used to confirm whether isolated strains were of the
O26 serogroup. Latex agglutination was performed using the Prolex E. coli non-O157 kit (Pro-Lab
Diagnostics Inc.), following the manufacturer’s instructions. Real-time PCR was as described previously.
Strain serogroup and stx subtype were further confirmed by whole-genome sequencing. Putative O26
strains were sequenced at the SERL using the Illumina MiSeq (Illumina, CA, U.S.) by paired-end sequenc-
ing (60). Sequence data were analyzed by the Public Health England bioinformatics pipeline installed at
the SERL and by BioNumerics v7.6 (Applied Maths, Ghent, Belgium) using the wgMLST and E. coli geno-
typing plug-in tools (60).
Statistical analysis. Chi square and Mann-Whitney U tests were performed in Minitab version 18.1
(Minitab Inc., PA, U.S.). A five-way Venn diagram was generated using the online tool provided at http://
bioinformatics.psb.ugent.be/webtools/Venn/ (Bioinformatics and Evolutionary Genomics, University of
Ghent, Belgium). Tetrachoric correlation analysis was performed on binary data using polycor in R.
Prevalence estimates. Herd-level and pat-level prevalence were estimated using a method similar
to that of Henry et al. (34). Briefly, a generalized linear mixed model with a logit link fitted with a random
herd effect to model extrabinomial variability was performed using Proc Glimmix (SAS version 9.4).
Mean estimates and CIs were generated by back transforming from the output on the logit scale.
Overall prevalence was estimated for each serogroup (O103, O145, O26) and stx subtype (stx1, stx2).
O111 was not included due to insufficient numbers. Prevalence estimates were also calculated for differ-
ent spatial (animal health district [AHD]) and temporal (season) factors. To enable comparisons with pre-
vious survey results, Scotland was divided into six AHDs (Highlands, Islands, Central, North East, South
East, and South West). Season was defined according to the following: spring (March to May), summer
(June to August), autumn (September to November), and winter (December to February).
Risk associations. Associations between the farm questionnaire data and herd-level presence/ab-
sence of non-O157 serogroups, together with STEC O157 (34), were performed using nonmetric multidi-
mensional scaling (NMS). PC-ORD software version 7.04 (MJM Software Design, Gleneden Beach, OR)
was used and analysis was performed on sample status results read at the global cutoff, with Border
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samples allocated to negative status. NMS was used with a grower distance measure. The dimensionality
of the data set was determined by plotting an inverse measure of fit (“stress”) to the number of dimen-
sions. Optimal dimensionality was based on the number of dimensions with the lowest stress. A two-
dimensional solution was shown to be optimal. Several NMS runs were performed for each analysis to
ensure that the solution was stable and represented a configuration with the best possible fit. On this
basis, 500 iterations were used for each NMS run, using random starting coordinates.
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